Authors |
Title |
References |
Links |
|---|---|---|---|
Blackwelder WC |
Showing a treatment is good because it is not bad: when does "noninferiority" imply effectiveness? |
Control Clin Trials. 2002 Feb;23(1):52-4. |
|
Connolly SJ |
Use and misuse of surrogate outcomes in arrhythmia trials |
Circulation. 2006 Feb 14;113(6):764-6. |
|
Dupont WD, Plummer WD Jr. |
Power and sample size calculations. A review and computer program. |
Control Clin Trials. 1990 Apr;11(2):116-28. |
|
Dupont WD, Plummer WD Jr |
PS: Power and Sample Size Calculation software. |
Vanderbilt Biostatistics |
|
Farcomeni A |
A review of modern multiple hypothesis testing, with particular attention to the false discovery proportion. |
Stat Methods Med Res. 2008 Aug;17(4):347-88. Epub 2007 Aug 14. Review |
|
Geller NL, Pocock SJ |
Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. |
Biometrics. 1987 Mar;43(1):213-23. |
|
Hoenig JM and Heisey DM |
The Abuse of Power: The Pervasive Fallacy of Power Calculations for Data Analysis. |
The American Statistician. 2001; 55(1): 19-24. |
|
Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA |
Caution regarding the use of pilot studies to guide power calculations for study proposals. |
Arch Gen Psychiatry. 2006 May;63(5):484-9. |
|
McFadden ET |
Data Management and Coordination. |
Encyclopedia of Biostatistics. 2005. Editors-in-chief Peter Armitage & Theodore Colton. Hoboken, NJ: Wiley Interscience. |
|
Meier P |
Statistics and medical experimentation. |
Biometrics. 1975 Jun;31(2):511-29. |
|
Meinert CL |
Clinical Trials, Overview. |
Encyclopedia of Biostatistics. 2005. Editors-in-chief Peter Armitage & Theodore Colton. Hoboken, NJ: Wiley Interscience. |
|
Moher D, Schulz KF, Altman DG; CONSORT GROUP (Consolidated Standards of Reporting Trials) |
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. |
Ann Intern Med. 2001 Apr 17;134(8):657-62. Review. |
|
Pocock SJ |
Statistical aspects of clinical trial design. |
The Statistician 1982; 31(1): 1-18. |
|
Potter DM |
Adaptive dose finding for phase I clinical trials of drugs used for chemotherapy of cancer. |
Stat Med. 2002 Jul 15;21(13):1805-23. |
|
Senn S |
Some controversies in planning and analysing multi-centre trials. |
Stat Med. 1998 Aug 15-30;17(15-16):1753-65; discussion 1799-800. Review. |
PubMed |
Senn S |
Crossover Designs. |
Encyclopedia of Biostatistics. 2005. Editors-in-chief Peter Armitage & Theodore Colton. Hoboken, NJ: Wiley Interscience. |
|
Simon R & Thall PF |
Phase II Trials. |
Encyclopedia of Biostatistics. 2005. Editors-in-chief Peter Armitage & Theodore Colton. Hoboken, NJ: Wiley Interscience. |
|
Stewart PW |
GCRC Protocols Which Propose "Pilot Studies." |
2004. Cincinnati Children’s Hospital. |
|
Storer BE |
Phase I Trials. |
Encyclopedia of Biostatistics. 2005. Editors-in-chief Peter Armitage & Theodore Colton. Hoboken, NJ: Wiley Interscience. |
|
Van Oortmarssen GJ |
Screening, Overview. |
Encyclopedia of Biostatistics. 2005. Editors-in-chief Peter Armitage & Theodore Colton. Hoboken, NJ: Wiley Interscience. |
|
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. |
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. |
Ann Intern Med. 2007 Oct 16;147(8):573-7. Erratum in: Ann Intern Med. 2008 Jan 15;148(2):168. |
|
Wittes J |
Adaptive Designs for Clinical Trials. |
Encyclopedia of Biostatistics. 2005. Editors-in-chief Peter Armitage & Theodore Colton. Hoboken, NJ: Wiley Interscience. |
|
Wright JG |
The minimal important difference: who's to say what is important? |
J Clin Epidemiol. 1996 Nov;49(11):1221-2. |
